Agios Pharm Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Agios Pharm Stock Summary

Agios Pharm competes with Mereo BioPharma, Blueprint Medicines, Day One, Biomarin Pharmaceutical, and Ideaya Biosciences. Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Agios Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 0 people.

Agios Pharm Key Financial Ratios

Agios Pharm Key Balance Sheet Accounts

Agios Pharm Key Income Statement Accounts

Agios Pharm Key Cash Accounts

Agios Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Agios Pharm's current stock value. Our valuation model uses many indicators to compare Agios Pharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Agios Pharm competition to find correlations between indicators driving Agios Pharm's intrinsic value. More Info.Agios Pharm is number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Agios Pharm's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Agios Pharm's earnings, one of the primary drivers of an investment's value.

Agios Pharm Systematic Risk

Today, most investors in Agios Pharm Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Agios Pharm's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Agios Pharm growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Agios Pharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Agios Pharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of Agios Pharm based on widely used predictive technical indicators. In general, we focus on analyzing Agios Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Agios Pharm's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.